These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2334443)
1. Metabolism of a novel nitrosourea, tauromustine, in the rat. Seidegård J; Grönquist L; Gunnarsson PO Biochem Pharmacol; 1990 May; 39(9):1431-6. PubMed ID: 2334443 [TBL] [Abstract][Full Text] [Related]
2. Metabolism of tauromustine in liver and lung microsomes from various species. Tuvesson H; Gunnarsson PO; Seidegård J Xenobiotica; 1999 Aug; 29(8):783-92. PubMed ID: 10553719 [TBL] [Abstract][Full Text] [Related]
3. Measurement and characterization of the denitrosation of tauromustine and related nitrosoureas by glutathione transferases in liver cytosol from various species. Tuvesson H; Gunnarsson PO; Seidegård J Carcinogenesis; 1993 Jun; 14(6):1143-7. PubMed ID: 8508500 [TBL] [Abstract][Full Text] [Related]
4. Involvement of FMN and phenobarbital cytochrome P-450 in stimulating a one-electron reductive denitrosation of 1-(2-chloroethyl)-3-(cyclohexyl)-1-nitrosourea catalyzed by NADPH-cytochrome P-450 reductase. Potter DW; Reed DJ J Biol Chem; 1983 Jun; 258(11):6906-11. PubMed ID: 6406492 [TBL] [Abstract][Full Text] [Related]
5. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases. Weber GF; Waxman DJ Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024 [TBL] [Abstract][Full Text] [Related]
6. Genotoxicity of tauromustine, a new water soluble taurine-based nitrosourea. I. Mutagenic and clastogenic activity of tauromustine in vitro. Hartley-Asp B Mutagenesis; 1992 Nov; 7(6):427-31. PubMed ID: 1474918 [TBL] [Abstract][Full Text] [Related]
7. Effects of tauromustine, a water-soluble nitrosourea compound on NMU-1 murine lung tumor. Pratesi G; Savi G Oncology; 1989; 46(2):132-5. PubMed ID: 2710478 [TBL] [Abstract][Full Text] [Related]
8. The nature of nitrosamine denitrosation by rat liver microsomes. Lorr NA; Tu YY; Yang CS Carcinogenesis; 1982; 3(9):1039-43. PubMed ID: 7139859 [TBL] [Abstract][Full Text] [Related]
9. Anti-tumour, toxicological and pharmacokinetic properties of a novel taurine-based nitrosourea (TCNU). Hartley-Asp B; Christensson PI; Gunnarsson K; Gunnarsson PO; Jensen G; Polacek J; Stamvik A Invest New Drugs; 1988 Apr; 6(1):19-30. PubMed ID: 3410663 [TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil causes alterations in the pharmacokinetic profile of tauromustine in NMRI mice. Hill SR; Bibby MC Cancer Chemother Pharmacol; 1994; 34(1):57-62. PubMed ID: 8174203 [TBL] [Abstract][Full Text] [Related]
11. The antitumor effect of a novel nitrosourea, tauromustine, at intravenous administration in rat. Cure of hepatomas. Roos G; el Hag IA; Christensson PI; Stenram U Anticancer Res; 1991; 11(5):1763-6. PubMed ID: 1837442 [TBL] [Abstract][Full Text] [Related]
12. Stereoselective monooxygenation of carcinostatic 1-(2-chloroethyl)-3-(cyclohexyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea by purified cytochrome P-450 isozymes. Potter DW; Levin W; Ryan DE; Thomas PE; Reed DJ Biochem Pharmacol; 1984 Feb; 33(4):609-13. PubMed ID: 6704177 [TBL] [Abstract][Full Text] [Related]
13. Relation between hepatic microsomal metabolism of N-nitrosamines and cytochrome P-450 species. Kawanishi T; Ohno Y; Takahashi A; Takanaka A; Kasuya Y; Omori Y Biochem Pharmacol; 1985 Apr; 34(7):919-24. PubMed ID: 3985997 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation. Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124 [TBL] [Abstract][Full Text] [Related]
15. The effect of a novel taurine nitrosourea, 1-(2-chloroethyl)-3-[2-(dimethylaminosulfonyl)ethyl]-1-nitrosour ea (TCNU) on cytotoxicity, DNA crosslinking and glutathione reductase in lung carcinoma cell lines. Tew KD; Dean SW; Gibson NW Cancer Chemother Pharmacol; 1987; 19(4):291-5. PubMed ID: 2954712 [TBL] [Abstract][Full Text] [Related]
16. Improved antitumor effect of the nitrosourea drugs tauromustine (TCNU) and carmustine (BCNU) on a rat liver adenocarcinoma after hepatic arterial administration with degradable starch microspheres. Roos G; el Hag IA; Teder H; Stenram U Anticancer Res; 1991; 11(1):13-6. PubMed ID: 2018346 [TBL] [Abstract][Full Text] [Related]
17. Role of isozymes of cytochrome P-450 in the metabolism of N,N-dimethyl-4-aminoazobenzene in the rat. Levine WG; Lu AY Drug Metab Dispos; 1982; 10(2):102-9. PubMed ID: 6124393 [TBL] [Abstract][Full Text] [Related]
18. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels. Chang TK; Chen H; Waxman DJ Drug Metab Dispos; 1994; 22(5):673-9. PubMed ID: 7835216 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of tauromustine in cancer patients. Phase I studies. Gunnarsson PO; Vibe-Petersen J; Macpherson JS; Warrington PS; Polacek J; Ellman M; Hansen HH; Smyth JF Cancer Chemother Pharmacol; 1989; 23(3):176-80. PubMed ID: 2924375 [TBL] [Abstract][Full Text] [Related]
20. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1. Hyland R; Gescher A; Thummel K; Schiller C; Jheeta P; Mynett K; Smith AW; Mráz J Mol Pharmacol; 1992 Feb; 41(2):259-66. PubMed ID: 1538706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]